Piekos Brian Insider Trades

Insider Trading History

Track insider trading activity for Piekos Brian. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jun 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.82M 215,411 shares
$27.00
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $585k 21,661 shares
Last Trade
May 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.9k 1,489 shares
$26.78
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $1.49M 55,000 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 5,000 shares
$26.77
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $625k 23,150 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 5,000 shares
$26.77
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $490k 18,150 shares
Last Trade
Apr 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.6k 1,862 shares
$20.22
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $2.53M 93,750 shares
Last Trade
Apr 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 6,250 shares
$19.56
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $540k 20,012 shares
Last Trade
Apr 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 6,250 shares
$19.56
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $372k 13,762 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 1,767 shares
$15.57
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $1.62M 60,000 shares
Last Trade
Feb 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$79.2k 5,000 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $419k 15,529 shares
Last Trade
Feb 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$79.2k 5,000 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $2.7M 100,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 100,000 shares
$14.60
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $284k 10,529 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$60.1k 4,471 shares
$13.45
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $1.76M 65,000 shares
Last Trade
Nov 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 15,000 shares
$13.10
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $405k 15,000 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$197k 15,000 shares
$13.10
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $2.16M 80,000 shares
Last Trade
Feb 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$802k 80,000 shares
$10.03
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Financial Officer
Holding Value $2.7M 100,000 shares
Last Trade
Sep 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.19M 100,000 shares
$11.87
$27.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Chief Financial Officer
Holding Value $178k 43,225 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 43,225 shares
$4.50
$4.11
Angion Biomedica
Angion Biomedica ANGN
Chief Financial Officer
Holding Value $75.5k 75,484 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.55M 75,484 shares
$100.00
$1.00
Elicio Therapeutics
Elicio Therapeutics ELTX
Chief Financial Officer
Holding Value $310k 75,484 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.55M 75,484 shares
$100.00
$4.11
Gemini Therapeutics
Gemini Therapeutics GMTX
CFO
Holding Value $23.8k 17,615 shares
Last Trade
May 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7k 9,960 shares
$1.28
$1.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up